Prime Medicine (PRME) Change in Receivables (2024 - 2025)
Prime Medicine (PRME) posted Change in Receivables of -$120000.0 for Q3 2025, down 216.5% on a QoQ basis from $103000.0 in Q2 2025, and down 100.22% year-over-year from $55.0 million in Q3 2024.
Prime Medicine (PRME) Change in Receivables (2024 - 2025) Analysis & Trends
Prime Medicine's Change in Receivables history runs 2 years deep, the most recent figure standing at -$120000.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prime Medicine | 525.98 Mn | 525.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -120,000.00 |
| Sep 30, 2025 | -120,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Sep 30, 2024 | 55.00 Mn |
| Sep 30, 2024 | 55.00 Mn |